AstraZeneca Vaccine: Clues to Rare Blood Clots ‘Trigger’ Studied by Scientists

The England-based pharmaceutical company said the full reasoning behind the bleeding condition has yet to be determined, and noted that coronavirus infections were more likely to cause it than the vaccine. “While the research is not definitive, it offers some interesting information, and AstraZeneca is exploring ways to exploit these findings as part of our efforts to remove this extremely rare side effect.”